TargetMol

Baicalein

Product Code:
 
TAR-T2858
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T2858-50mg50mg£97.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2858-100mg100mg£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2858-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Baicalein is a xanthine oxidase inhibitor.
CAS:
491-67-8
Formula:
C15H10O5
Molecular Weight:
270.24
Pathway:
Immunology/Inflammation; Microbiology/Virology; Apoptosis; Cell Cycle/Checkpoint; Metabolism
Purity:
0.9579
SMILES:
Oc1cc2oc(cc(=O)c2c(O)c1O)-c1ccccc1
Target:
Ferroptosis; Influenza Virus; ROS; Xanthine Oxidase

References

1. Shieh DE,et al. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res. 2000 Sep-Oct;20(5A):2861-5. 2. Xing-Cong M , Wanjun Y , Zhijun D , et al. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/?-catenin pathway[J]. Drug Design, Development and Therapy, 2016:1419-. 3. Kong EK, et al. A novel anti-fibrotic agent, baicalein, for the treatment of myocardial fibrosis in spontaneously hypertensiverats. Eur J Pharmacol. 2011 May 11;658(2-3):175-81. 4. Meng X, Mao Z, Li X, et al. Baicalein decreases uric acid and prevents hyperuricemic nephropathy in mice[J]. Oncotarget. 2017, 8(25): 40305.